Skip to main content
. 2018 May 18;37(35):4871–4886. doi: 10.1038/s41388-018-0302-4

Fig. 1.

Fig. 1

pancEts-1 is a lncRNA associated with poor survival of gastric cancer. a Scheme indicating the existence of pancEts-1 transcribed upstream the Ets-1 promoter region. b RNA fluorescence in situ hybridization images showing the nuclear and cytoplasmic localization of pancEts-1 in MKN-45 cells using a 138-bp antisense probe (red), with the nuclei staining by DAPI (blue). Sense probe and antisense probe with RNase A (20 μg) treatment were used as negative controls. Scale bars: 10 μm. c Real-time qRT-PCR assay revealing the pancEts-1 transcript levels (normalized to β-actin) in normal gastric mucosa (n = 30) and cultured gastric cancer cell lines (mean ± SD, n = 5). d Real-time qRT-PCR assay indicating the differential expression of pancEts-1 transcript (normalized to β-actin) in normal gastric mucosa (n = 30) and gastric cancer tissues (n = 81). e, f Real-time qRT-PCR assay showing the pancEts-1 transcript levels (normalized to β-actin) in gastric cancer tissues with differential status of metastasis (e) or Ets-1 immunostaining (f). g The positive correlation between pancEts-1 and Ets-1 transcript levels in gastric cancer tissues (n = 81). h Kaplan–Meier curves indicating overall survival of 81 gastric cancer patients (cutoff value = 2.833) and overall (OS) and first progression (FP) survival of those derived from Kaplan-Meier plotter with low or high pancEts-1 expression (cutoff values = 14.0 and 14.0). Student’s t test compared gene expression levels in cf. Pearson’s correlation coefficient analysis in g. Log-rank test for survival comparison in h